| Literature DB >> 14987983 |
Romano Silvestri1, Marino Artico, Giuseppe La Regina, Gabriella De Martino, Massimiliano La Colla, Roberta Loddo, Paolo La Colla.
Abstract
A SAR study has been performed in order to evaluate how much the ester function could be a determinant for the anti-human immunodeficiency virus type-1 activity of pyrryl aryl sulfones (PASs), a potent family of non-nucleoside reverse transcriptase (RT) inhibitors discovered in the last years. Twenty-three new esters were prepared with the aim to enhance the inhibitory potency of 4a and 4c, two PAS agents endowed with good activity (EC50 = 0.14 microM) and deprived of cytotoxicity up to >200 microM. None of test derivatives was as potent as 4a and 4c and lacked of selectivity due to their higher cytotoxicity (compounds 22-25). Antiviral activity correlate with an ester ramified chain.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14987983 DOI: 10.1016/j.farmac.2003.11.004
Source DB: PubMed Journal: Farmaco ISSN: 0014-827X